Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation

Bone Marrow Transplantation

Volumn 19, Issue 5, 1997, Pages 487-490

  Salat, C ^a   Holler, E ^a,b   Wolf, C ^c   Kolb, H J ^a,b   Reinhardt, B ^a   Pihusch, R ^a   Kramling H J ^d   Heinemann, V ^a   Haller, M ^e   Hiller, E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Hamatologikum der GSF Neuherberg   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Paracelsuskrankenhaus Ruit   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aminopropeptide of type III collagen; Bone marrow transplantation; Liver transplantation; Plasminogen activator inhibitor 1 (PAI 1); Veno occlusive disease

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN DERIVATIVE; COLLAGEN TYPE 3 AMINOPROPEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; INFECTIOUS COMPLICATION; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0031040311     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700689     Document Type: Article

References (21)

1. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
2. Salat C, Holler E, Kolb HJ, Hiller E. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen (letter). Lancet 1993; 342: 1062.
3. Salat C, Holler E, Reinhardt B et al. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant 1994; 14: 747-750.
4. Eltumi M, Trivedi P, Hobbs JR et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993; 342: 518-521.
5. Heikinheimo M, Halila R, Fasth A. Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Blood 1994; 83: 3036-3040.
6. Rio B, Bauduer F, Arrago JP, Zittoun R. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant 1993; 11: 471-472.
7. Blanz J, Rosenfeld C, Proksch B, Ehninger G. Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis. J Chromatogr 1990; 532: 429-437.
8. Mc Donald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
9. Shulman HM, Fisher LB, Schoch HG et al. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171-1177.
10. Baglin TP, Harper P, Marcus RE. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplant 1990; 5: 439-441.
11. Bearman SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator (tPA) for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 2458-2462.
12. Pralong G, Calandra T, Glauser MP et al. Plasminogen activator inhibitor 1: a prognostic marker in septic shock. Thromb Haemostas 1989; 61: 459-162.
13. Philippe J, Offner F, Declerck PJ et al. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb Haemostas 1991; 65: 291-295.
14. Salat C, Boekstegers P, Holler E et al. Hemostatic parameters in sepsis patients treated with anti-TNFα-monoclonal antibodies. Shock 1996; 6: 233-237.
15. Faioni EM, Krachmalnikoff A, Bearmān SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of vene-occclusive disease of the liver. Blood 1993: 81: 3458-3462.
16. Scrobohaci L, Drouet L, Monem-Mansi A et al. Liver venoocclusive disease after bone marrow transplantation. Changes in coagulation parameters and endothelial cell markers. Thromb Res 1991; 63: 509-519.
17. Gordon GB, Haire WD, Kessinger A et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991; 8: 497-503.
18. Harper PL, Jarvis J, Jennings I et al. Changes in the natural anticoagulants following bone marrow transplantation. Bone Marrow Transplant 1990; 5: 39-42.
19. Kaufmann PA, Jones RB, Greenberg CS, Peters WP. Autologous bone marrow transplantation and Factor XII, VII, and protein C deficiencies. Cancer 1990; 66: 515-521.
20. Leblond V, Salehian BD, Borel C et al. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients. Bone Marrow Transplant 1993; 11: 299-305.
21. Collins P, Roderick A, O'Brien D et al. Factor VIIa and other hemostatic variables following bone marrow transplantation. Thromb Haemostas 1994; 72: 28-32.